MicroRNA-137 in Schizophrenia: A Bioinformatics-Based Marker for Early Detection

Abstract

Schizophrenia is a serious mental health disorder that affects thinking, emotions, and behavior, but it is often diagnosed only after symptoms appear. Bioinformatics offers a way to find genetic biomarkers that could improve early detection. In this research paper, the National Human Genome Research Institute–European Bioinformatics Institute Genome-Wide Association Studies Catalog (NHGRI–EBI GWAS Catalog) was searched using the term “schizophrenia”. The catalog collates the results of genome-wide association studies, which identify genetic variants contributing to diseases by comparing the DNA of those affected with specific conditions against the DNA of the general population. From this search, three of the most frequently reported genes were found: CACNA1C, GRIN2A, and MIR137HG (miR-137), which appear much more often in schizophrenia studies than in studies of other traits. CACNA1C and GRIN2A are important because they affect specific brain pathways, such as calcium channel function and glutamate signaling. MiR-137 is different because it does not code for a protein but instead regulates hundreds of other genes, including CACNA1C and GRIN2A. This wider influence connects miR-137 to processes such as neuronal growth, learning, and memory which are all areas disrupted in schizophrenia. These findings highlight miR-137 as a promising biomarker candidate and show how bioinformatics can turn large genetic datasets into insights for earlier and more precise mental health care.